Strongbridge Biopharma plc – NASDAQ:SBBP
Strongbridge Biopharma stock price today
$2
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 6 hours
Strongbridge Biopharma stock price monthly change
-10.71%
month
Strongbridge Biopharma stock price quarterly change
-35.06%
quarter
Strongbridge Biopharma stock price yearly change
-7.41%
year
Strongbridge Biopharma key metrics
Market Cap | N/A |
Enterprise value | 89.68M |
P/E | -3.36 |
EV/Sales | 2.58 |
EV/EBITDA | -2.76 |
Price/Sales | 3.89 |
Price/Book | 3.04 |
PEG ratio | -0.23 |
EPS | -0.64 |
Revenue | 34.72M |
EBITDA | -32.39M |
Income | -40.16M |
Revenue Q/Q | 29.40% |
Revenue Y/Y | 34.97% |
Profit margin | -115.66% |
Oper. margin | -124.18% |
Gross margin | 95.02% |
EBIT margin | -124.18% |
EBITDA margin | -93.29% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeStrongbridge Biopharma stock price history
Strongbridge Biopharma stock forecast
Strongbridge Biopharma financial statements
| Sep 2020 | 8.07M | -3.15M | -39.14% |
|---|---|---|---|
| Dec 2020 | 8.22M | -11.94M | -145.22% |
| Mar 2021 | 8.38M | -11.81M | -140.94% |
| Jun 2021 | 10.04M | -13.24M | -131.86% |
| 2021-03-03 | -0.12 | -0.11 |
|---|---|---|
| 2021-05-12 | -0.1 | -0.11 |
| 2021-08-05 | -0.12 | -0.21 |
| Sep 2020 | 117646000 | 43.07M | 36.62% |
|---|---|---|---|
| Dec 2020 | 121100000 | 55.49M | 45.83% |
| Mar 2021 | 108050000 | 52.20M | 48.31% |
| Jun 2021 | 96820000 | 52.42M | 54.15% |
| Sep 2020 | -5.75M | -10K | 27.65M |
|---|---|---|---|
| Dec 2020 | -5M | 0 | 10.72M |
| Mar 2021 | -13.39M | -10K | -221K |
| Jun 2021 | -9.82M | 0 | -297K |
Strongbridge Biopharma alternative data
| Aug 2023 | 72 |
|---|---|
| Sep 2023 | 72 |
| Oct 2023 | 72 |
| Nov 2023 | 72 |
| Dec 2023 | 72 |
| Jan 2024 | 72 |
| Feb 2024 | 72 |
| Mar 2024 | 72 |
| Apr 2024 | 72 |
| May 2024 | 72 |
| Jun 2024 | 72 |
| Jul 2024 | 72 |
Strongbridge Biopharma other data
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Sep 2020 | 1487377 | 0 |
| Quarter | Transcript |
|---|---|
| Q1 2021 12 May 2021 | Q1 2021 Earnings Call Transcript |
| Q4 2020 3 Mar 2021 | Q4 2020 Earnings Call Transcript |
| Q3 2020 31 Oct 2020 | Q3 2020 Earnings Call Transcript |
| Q2 2020 4 Aug 2020 | Q2 2020 Earnings Call Transcript |
Tuesday, 5 October 2021 | ||
| Xeris Pharmaceuticals Completes Acquisition of Strongbridge Biopharma | Business Wire | |
| Strongbridge Biopharma plc Announces Completion of Acquisition by Xeris Pharmaceuticals, Inc. | GlobeNewsWire | |
Thursday, 23 September 2021 | ||
| Strongbridge Biopharma plc Announces Court Hearing Date to Approve Proposed Acquisition by Xeris Pharmaceuticals, Inc. | GlobeNewsWire | |
Wednesday, 8 September 2021 | ||
| Strongbridge Biopharma plc Announces Shareholder Approval of Proposed Acquisition by Xeris Pharmaceuticals, Inc. | GlobeNewsWire | |
Tuesday, 31 August 2021 | ||
| Second Leading Independent Proxy Advisory Firm Glass Lewis Recommends Strongbridge Biopharma plc Shareholders Vote “FOR” the Transaction With Xeris | GlobeNewsWire | |
Monday, 30 August 2021 | ||
| Leading Independent Proxy Advisory Firm ISS Recommends Strongbridge Biopharma plc Shareholders Vote “FOR” the Transaction With Xeris | GlobeNewsWire |
-
What's the price of Strongbridge Biopharma stock today?
One share of Strongbridge Biopharma stock can currently be purchased for approximately $2.
-
When is Strongbridge Biopharma's next earnings date?
Unfortunately, Strongbridge Biopharma's (SBBP) next earnings date is currently unknown.
-
Does Strongbridge Biopharma pay dividends?
No, Strongbridge Biopharma does not pay dividends.
-
What is Strongbridge Biopharma's stock symbol?
Strongbridge Biopharma plc is traded on the NASDAQ under the ticker symbol "SBBP".
-
What is Strongbridge Biopharma's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Strongbridge Biopharma?
Shares of Strongbridge Biopharma can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Strongbridge Biopharma have?
As Jul 2024, Strongbridge Biopharma employs 72 workers.
-
When Strongbridge Biopharma went public?
Strongbridge Biopharma plc is publicly traded company for more then 10 years since IPO on 10 Sep 2015.
-
What is Strongbridge Biopharma's official website?
The official website for Strongbridge Biopharma is strongbridgebio.com.
-
Where are Strongbridge Biopharma's headquarters?
Strongbridge Biopharma is headquartered at 900 Northbrook Dr Ste 200, Trevose, PENNSYLVANIA.
-
How can i contact Strongbridge Biopharma?
Strongbridge Biopharma's mailing address is 900 Northbrook Dr Ste 200, Trevose, PENNSYLVANIA and company can be reached via phone at +1 610 254 9200.
Strongbridge Biopharma company profile:
Strongbridge Biopharma plc
strongbridgebio.comExchange:
NASDAQ
Full time employees:
72
Industry:
Biotechnology
Sector:
Healthcare
Strongbridge Biopharma plc, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs. The company offers Keveyis, an oral carbonic anhydrase inhibitor for treating hyperkalemic, hypokalemic, and related variants of primary periodic paralysis in the United States. Its clinical-stage product candidates include Recorlev, a cortisol synthesis inhibitor, which is in a Phase III clinical trials that for the treatment of endogenous Cushing's syndrome; and Veldoreotide, a somatostatin analog that completed Phase II clinical trial for the treatment of acromegaly. The company was formerly known as Cortendo plc and changed its name to Strongbridge Biopharma plc in September 2015. Strongbridge Biopharma plc was founded in 1996 and is headquartered in Trevose, Pennsylvania.
900 Northbrook Dr Ste 200
Trevose, PENNSYLVANIA
Trevose, PENNSYLVANIA
CIK: 0001634432
ISIN: IE00BYZ5XL97
CUSIP: G85347105
